Nano Biopharma Private Limited
About Nano Biopharma Private Limited
Data last updated:
Nano Biopharma Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the business and IT consulting segment of the business process outsourcing sector. It was incorporated on 03 September 2008 and has been in existence for over 18 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24232DL2008PTC182811. Its GSTIN is 07AACCN8690E1Z9 (Delhi).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹6.9 Lakh. It is led by directors Shalini Diwan and Parag Diwan.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at B – 163 Sheikh Sarai Phase – I, New Delhi, Delhi, India – 110017.
As per the financials filed for FY 2024, the company reported a revenue of ₹59.94 Lakh, a growth of 76% compared to the previous year. For the same year it recorded a net profit of ₹7.13 Lakh (net margin 11.9%) and EBITDA of ₹10.41 Lakh (EBITDA margin 17.4%). Revenue has grown at a compounded annual rate (CAGR) of 68% over three years and 16% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Nano Biopharma Private Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressB – 163 Sheikh Sarai Phase – I, New Delhi, Delhi, India – 110017
- IndustryBusiness Outsourcing, Business & IT Consulting
To see the full contact details of Nano Biopharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Nano Biopharma is professional, scientific and technical. In detail, this covers management consultancy activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M3 | Management consultancy activities |
To see the full business activity and turnover split of Nano Biopharma Private Limited, buy the company report.
Financials of Nano Biopharma Private Limited
FY 2025 filings availableNano Biopharma Private Limited reported revenue of ₹59.94 Lakh (up 76% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 16% over five years, including 76% growth in the latest year. EBITDA rose 67% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹10.41 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹7.13 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 17.4% | ||||
| Net Profit Margin | 11.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Nano Biopharma Private Limited, buy the company report.
Board of directors of Nano Biopharma Private Limited
Nano Biopharma has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shalini Diwan | Director | 03 Sep 2008 | 18 Years 2 Months | Current |
| Parag Diwan | Director | 03 Sep 2008 | 18 Years 2 Months | Current |
Auditor
Nano Biopharma Private Limited is audited by M.D. Gujrati & co. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| M.D. Gujrati & co. | FY 2023 | 005301N |
Shareholding
The shareholding of Nano Biopharma Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Nano Biopharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Nano Biopharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Nano Biopharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Nano Biopharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AACCN8690E1Z9 | Delhi | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Nano Biopharma Private Limited, buy the company report.
Recent activity
Nano Biopharma Private Limited has 2 board changes on record since 2008: 2 appointments. The latest: Parag Diwan was appointed as Director on 03 Sep 2008.
Frequently asked questions
Nano Biopharma is an active private limited company based in New Delhi, Delhi, India. The company works in business and IT consulting, within the business outsourcing industry. It was incorporated on 03 September 2008 (18+ years old) and is registered under CIN U24232DL2008PTC182811.
Nano Biopharma has 2 current directors:
- Shalini Diwan - Director
- Parag Diwan - Director
The latest financial statements of Nano Biopharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Nano Biopharma is 07AACCN8690E1Z9, registered in Delhi.
The CIN (Corporate Identification Number) of Nano Biopharma is U24232DL2008PTC182811. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Nano Biopharma was incorporated on 03 September 2008, making it 18+ years old. It is registered with the Registrar of Companies, Delhi.
Parag Diwan was appointed as Director on 03 Sep 2008. Shalini Diwan was appointed as Director on 03 Sep 2008.
The registered office of Nano Biopharma is at B – 163 Sheikh Sarai Phase – I, New Delhi, Delhi, India – 110017.
Nano Biopharma operates in the business outsourcing industry, in the business and IT consulting segment.
The compliance status of Nano Biopharma is compliant as of 18 August 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
